Saitama Cancer Center

Kitaadachi, Saitama 362-0806

1 studies enrolling now · 3 studies all time

What they study most

Advanced Non-small Cell Lung Cancer, HER2 Mutation, Colorectal Cancer, Gastric Cancer, Gastroesophageal Junction Cancer

Studies at this site

• A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now
• A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer — Completed
• A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer — Completed